Navigating drug development in oncology is a complex and intensive process. While challenges are common in later phases, early-phase oncology (EPO) studies present their own unique obstacles. If left unaddressed, these challenges can significantly impact the complexity of later stages.

In this upcoming webinar, we’ll delve into the unique challenges encountered by sponsors during clinical development. These challenges span regulatory hurdles, patient recruitment, data quality, and study design. Additionally, we’ll share best practices for addressing EPO study obstacles, ranging from optimizing study design to efficient site selection.

Australia, with its untapped potential, plays a pivotal role in accelerating clinical trials. Our webinar will feature a real-world case study, where we’ll explore a clinical development plan showcasing successful escalation and optimization strategies. Notably, this case study underscores Australia’s significant role in mitigating these challenges.